KLF2 and KLF4 are proved to be highly expressed in the endothelium during the episodes of IRI and responsible for disease progression (39, 40), while KLF6 targeting improved IRI-induced AKI through effects on inflammation, apoptosis, and renal function (41). The gene discussed is KLF2; the disease is acute kidney injury.